OSF Ventures

OSF Ventures, founded in 2015 and based in Peoria, Illinois, is the corporate venture arm of OSF HealthCare. It focuses on investing in companies that aim to enhance patient outcomes, improve patient experiences, and lower healthcare costs. OSF Ventures adopts a collaborative approach, combining financial investment with strategic partnerships to foster innovation in health information technology, medical devices, therapeutics, diagnostics, and technology-enabled delivery sectors. The organization is rooted in the mission and values of OSF HealthCare, emphasizing compassion, integrity, teamwork, and stewardship. By employing principles of humble curiosity and thoughtful risk-taking, OSF Ventures seeks to challenge conventional practices and advocate for more compassionate healthcare solutions for all.

Kevin Fahey

Founder and Director

Stan Lynall

Vice President of Venture Investments

Robert Sehring

Founder and CEO

Mayank Taneja

Vice President, Venture Investments

Past deals in Illinois

PhotoniCare

Series A in 2020
PhotoniCare, Inc. is a medical device company based in Champaign, Illinois, founded in 2013. The company specializes in developing innovative diagnostic tools for middle ear infections, notably the TOMi Scope. This handheld device employs advanced light-based technology, specifically near-infrared light waves, to create 3D images of the middle ear by seeing through the eardrum. This capability allows physicians to visualize the middle ear directly and safely, enabling them to assess its condition quickly and accurately. By determining the contents of the middle ear, clinicians can make informed decisions regarding the need for antibiotics or surgical interventions. PhotoniCare's technology not only addresses otology but also presents potential for growth in other medical fields.

Endotronix

Series D in 2018
Endotronix is a developer of hemodynamic monitoring technologies to help detect worsening heart failure earlier than ever before. The company's platform includes a cloud-based disease management data system and outpatient hemodynamic management with a breakthrough implantable wireless pulmonary artery sensor for early detection of worsening heart failure. It was founded in 2007 and is based in Lisle, Illinois.

Level Ex

Corporate Round in 2018
Level Ex, Inc. is a Chicago-based company that develops virtual surgery mobile applications aimed at enhancing the skills of physicians through immersive training experiences. The company offers a platform called Virtual Technique Guides, which leverages cloud gaming technology to facilitate interactive surgical training. This platform allows surgeons to perform virtual procedures alongside medical device sales representatives in a web conferencing environment. Additionally, Level Ex has developed Airway EX, an app tailored for mastering critical endoscopic and interventional airway procedures. This application addresses various medical scenarios, including managing obstructing tumors, vocal cord injuries, and complex intubations in both adult and pediatric patients. Founded in 2015, Level Ex combines video game technology and cognitive neuroscience to provide physicians with tools to navigate rare medical cases, new medical devices, and evolving drug therapies.

AVIA

Series C in 2016
AVIA Inc. is a digital transformation partner for healthcare organizations, founded in 2012 and based in Chicago, Illinois. The company specializes in developing a knowledge-sharing and collaboration platform that offers market intelligence, collaborative tools, and results-based consulting services. AVIA aims to address the strategic challenges faced by healthcare providers by facilitating access to a network of health systems and strategic partners. Their platform allows healthcare leaders to research, evaluate, and select digital health solutions, while also engaging with expert consultants to guide them through the digital transformation process. This comprehensive approach enables healthcare enterprises to innovate and achieve digital success effectively.

Endotronix

Series C in 2016
Endotronix is a developer of hemodynamic monitoring technologies to help detect worsening heart failure earlier than ever before. The company's platform includes a cloud-based disease management data system and outpatient hemodynamic management with a breakthrough implantable wireless pulmonary artery sensor for early detection of worsening heart failure. It was founded in 2007 and is based in Lisle, Illinois.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.